• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Bio-Rad Laboratories IncClass A (BIO)

Equity
Sell: $296.69|Buy: $305.28|Change: 3.82 (-1.25%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Address

1000 Alfred Nobel Drive
Hercules
CA
USA
94547

Telephone

+1 510 7247000

Website

https://www.bio-rad.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Bio-Rad Laboratories Inc Third Quarter Earnings Conference Call for 20262026-10-29T17:00:00
Bio-Rad Laboratories Inc Third Quarter Earnings Results for 20262026-10-29T00:00:00
Bio-Rad Laboratories Inc Second Quarter Earnings Conference Call for 20262026-07-31T17:00:00
Bio-Rad Laboratories Inc Second Quarter Earnings Results for 20262026-07-31T00:00:00
Bio-Rad Laboratories Inc First Quarter Earnings Conference Call for 20262026-05-01T17:30:00
Bio-Rad Laboratories Inc First Quarter Earnings Results for 20262026-05-01T00:00:00
Bio-Rad Laboratories Inc Annual General Meeting for 20262026-04-22T16:00:00
Bio-Rad Laboratories Inc Fourth Quarter Earnings Conference Call for 20252026-02-13T17:00:00
Bio-Rad Laboratories Inc Fourth Quarter Earnings Results for 20252026-02-13T00:00:00
Bio-Rad Laboratories Inc Annual Report for 20252026-02-13T00:00:00

Previous key dates

NameKey Date
Bio-Rad Laboratories Inc Third Quarter Earnings Conference Call for 20252025-10-29T17:00:00
Bio-Rad Laboratories Inc Third Quarter Earnings Result for 20252025-10-29T00:00:00
2025 Wells Fargo Healthcare Conference2025-09-04T12:45:00
Bio-Rad Laboratories Inc Second Quarter Earnings Conference Call for 20252025-07-31T17:00:00
Bio-Rad Laboratories Inc Second Quarter Earnings Results for 20252025-07-31T00:00:00
2025 RBC Capital Markets Global Healthcare Conference2025-05-21T13:35:00
Bio-Rad Laboratories Inc First Quarter Earnings Conference Call for 20252025-05-01T17:30:00
Bio-Rad Laboratories Inc First Quarter Earnings Result for 20252025-05-01T00:00:00
Bio-Rad Laboratories Inc Annual General Meeting for 20252025-04-22T16:00:00
Bio-Rad Laboratories Inc Annual Report for 20242025-02-14T00:00:00
Bio-Rad Laboratories Inc Fourth Quarter Earnings Conference Call for 20242025-02-13T17:00:00
Bio-Rad Laboratories Inc Fourth Quarter Earnings Result for 20242025-02-13T00:00:00
43rd Annual J.P. Morgan Healthcare Conference2025-01-16T14:30:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.